Stocks to sell

I’ve been waiting to write about iBio (NYSEAMERICAN:IBIO) in order to see their earnings report and give readers a better handle on the latest IBIO news. As usual, there is nothing worth investing in with this company. Most investors should stay far away from IBIO stock. Source: Shutterstock In fact, the only thing of note

Would you pay 30 times revenue for a money-losing “growth” company that had stopped growing? But that’s where Beyond Meat (NASDAQ:BYND) finds itself after reporting a loss of $19.3 million, 31 cents per share, for the quarter ending in September. Sales for Beyond Meat stock came to $94.4 million, up just 2.7% from a year

Total return. That’s a combination of growth and the dividend a stock returns. The dividend is kind of like a guaranteed return, even if the stock doesn’t perform or the market rolls over. That’s why companies that offer dividends are considered shareholder friendly. They return some of their net profits to their investors and generally

Near the $50 per share price level, will Nio (NYSE:NIO) climb even higher? It’s possible. After a strong earnings report, investors remain confident in the China-based electric vehicle (EV) maker’s prospects. Sure, its projected growth makes it worthy of a premium valuation. Yet, it’s questionable whether today’s share price overestimates its long-term prospects. Source: Robert

Nikola (NASDAQ:NKLA), which is down 53.93% over a three month period, is evidence that even though the electric vehicle (EV) sector is on fire at the moment, you should exercise caution. Not every company is primed to be a multi-bagger. Case in point, Nikola stock Source: Stephanie L Sanchez / Shutterstock.com The company has no

With the crazy world we’re living in, it was almost inevitable that the markets had at least one more surprise in store. Sure enough, a big one came last week in the form of a very positive third-quarter earnings report for ElectraMeccanica (NASDAQ:SOLO). The niche electric-vehicle (EV) manufacturer, specializing in the three-wheeled, single-seater Solo, reported

Since I last wrote about Electrameccanica Vehicles (NASDAQ:SOLO) the bullish crowd has made my skepticism look positively absurd. SOLO stock is up almost 150% in the last month (as of this writing). That’s a pretty big can of crow investors are putting on my plate. And I’ll admit to a misstatement in my recent article

The shares of Inovio Pharmaceuticals (NASDAQ:INO) were on fire this spring after the company had become one of the leaders of the Covid-19 vaccine race. INO stock soared 860% in the first half of the year, comfortably beating the majority of its peers. Source: Shutterstock However, due to the lack of detail in the company’s

Beyond Meat (NASDAQ:BYND) reported its Q3 earnings on November 9 and they showed a significant slowing in revenue and profits. So why is Beyond Meat stock still trading as if the company’s growth is accelerating? This is not likely to last much further. Source: calimedia / Shutterstock.com Beyond Meat stock trades at very high multiples

If you had to pick one sector that you can rely on when things get difficult, sin stocks would represent an incredibly tempting proposition. While companies based on a cynical or even outright lurid business model are often attractive in the best of times, it’s at our worst when this sector has a powerful draw.

Hexo Corp. (NYSE:HEXO) has fallen substantially since my article in August 2019 on the stock. HEXO stock has lost over $700 million in market value in that period, falling from $1.1 billion to $360 million over that period. Source: Shutterstock That’s the sign of a loser stock and unimaginative management that don’t understand how markets

I’ll admit to knowing nothing about Ever-Glory International (NASDAQ:EVK), a China-based apparel manufacturer and retailer, before I conducted research for this column. But I knew there had to be something about EVK stock that was drawing the attention of our readers. A quick glance shows some significant price action and a surge of trading volume

In July 2020, McKinsey indicated that 250 vaccine candidates are being pursued globally. The consulting firm also estimated that between five to seven vaccines would be approved in the next two years. Inovio Pharmaceuticals (NASDAQ:INO) has been in the race for the vaccine against Covid-19 and INO stock has exhibited high volatility. Source: Ascannio /

Some stories — you know, crazy pandemics, crazier elections, craziest wardrobe fails — make so many headlines these days that they’ve shoved otherwise major developments off to the side. One of those, 5G technology, promises to change mobile communications like nothing else in generations. Vying for a nice slice of the pie is Nokia (NYSE:NOK),

It’s been an incredible comeback year for iBio (NYSEAMERICAN:IBIO). Up until 2020, IBIO stock had a long and unfortunate run as a publicly traded investment. Shares dropped from a peak of $55 each in 2011 to as low as 5 cents last year. However, for the fledgling biotech and vaccine company, the novel coronavirus gave it

Vehicle rental company Hertz Global (OTCMKTS:HTZGQ) and Hertz stock is no longer traded on the New York Stock Exchange. On Oct. 29, Intercontinental Exchange (NYSE:ICE), which owns the NYSE announced, “the staff of NYSE Regulation has determined to suspend trading in the common stock of Hertz Global Holdings, Inc. (the “Company”) — ticker symbol HTZ —

As the world’s second-largest economy with a middle class that’s still significantly expanding, China represents an investor’s dream market. Frankly, without the country, many companies would cease to exist because they were originally tied to now-matured sectors. But the allure of China is also its pitfall. As an investor, you must be careful to avoid

There are investors out there who see this market as being in a bubble, or something close. And I’d expect many of those investors would point to Exxon Mobil (NYSE:XOM) stock as “Exhibit A” in their argument. Source: Harry Green / Shutterstock.com After all, many growth stocks that are barely profitable — or not profitable

A Nov. 9 press release from Pennsylvania-based mergers and acquisition litigation specialist Brodsky & Smith LLC caught my attention. It centers around the pending merger between special purpose acquisition company Landcadia Holdings II (NASDAQ:LCA) and Golden Nugget Online Gaming Inc. If you own LCA stock, you might want to reconsider your position. Source: rawf8/Shutterstock.com Here’s

On Monday, Pfizer (NYSE:PFE) announced a breakthrough in its search for a novel coronavirus vaccine. The company’s candidate — developed in partnership with Biontech (NASDAQ:BNTX) — has now reached 90% efficacy in preventing the disease in healthy volunteers. Needless to say, this news came as a bolt out of the blue. Prior to the big announcement,